and update for XXXX thanks Thank call. afternoon. joining QX our good you, And shareholder
midyear well our bit more to color chance our Now had some like a towards. provide our I'd the and that stand to of are growth, you've working a cost as recent on and where quarterly as results, revenues, review initiatives releases as see press savings we we initiatives, to
capital overhang such structures eliminate ATM, cash We stock. the main can that financial to will breakeven longer independence. the cover and for all create That burn. to raise we is vehicles no we as an reach these Our means on need roll the goal XXXX to
creating things two share We are capital, Revenue fact the things on to two growth That's and is company on the needing of reduction. the is and cash raise our that more dilution why fully management further to laser-focused burn risk weight the price of shareholders. biggest aware only.
of like more flavor those I'd press today, both bit give time beyond to on releases. reports a aspects So the recent and you to a spend some of
Let's revenue with start growth.
know, Products revenue two our and have Division. you generating Pathology Services our Division As we divisions,
Services Division, very goals, the the which Pathology are start simple. let's with For
Given average the point approximately million per per and quarter gross unit rate, our million case which for under little breakeven translates or million mix, $X.X annual division revenue margin, into $XX run is a the per month. X.X
In in that XX% $X.X QX, million or revenues of goal. did we
continue [NGS breakeven testing] good our sense that reaching as the end or in as the in path customers pretty new of we and have history, However, about in to by we expect division. guidance, about we million My goal XX% of with my we're goal. that very the that towards Pathology well of need to. the on is to year achieving in-house, first direction we the shy right much a of addition trending at July, we company for the where and exceeded the get are is, Without $X of time and the chance reaching goal point the and providing $XXX,XXX
to Moving well here all on we fronts. Products see continued the growth Division, as
little breakeven. equals target. goal rate division, XX% per million We run approximately is to is of $XXX,XXX entire reach $X an the annual to company the under the bringing the ended products the $X which quarter a which For million quarter
customer a step and contrast revenues manner, increase growth to in we product the on the side, However, the the gradual bigger the in step. the And add. the on customer, pathology greater side study
we see we what forward. going look at let's got So and what our growth -
three closer that things achieve move to We us continue to that goal.
case ongoing because customers to new it's stream base. predictable relatively volume The is our First, is customer revenue the to grow continue add driven which customer's we constant. by
So blocks building of annuity customer revenue. our an stream each the revenue to of adds that creates
existing these to ongoing panels predictable continue create additional adoption will customers. This of a per adds customer and panels Second, stream. those and see increases also revenue building to constant we by the blocks revenue and
point margin out that predictability business. to runs, not we et materials, to terms cetera, operational important which business, an forecasting. better projections incredibly just of purchasing elements revenue like production significant perspective, efficiencies I'd this all costs, in inventory and for is of as the up drive the scale gross From raw creates the this
pipeline. our is Third,
As work to growth. we open with pipeline and doors that new distributors, to we continue our with continue to key customers
annual pipeline at of more a As as are in we we we've we grow pipeline, today's to we're today, pipeline close expect opportunities. XX% will there. million we of and If continue $XX over revenue, said the looking the that add
thing already current be and product is to competing will ours. believe other customers, Another excuse their recently looking the broadening superior all to our far from - We the are me offering. BCR/ABL game-changer discuss products of a panel, to we're HemeScreen I'd new switching by assay our market. who It announced is a which I seeing like at in
as only additions this into a nor it's boost customer excited a laboratories because will pipeline, impact really to our provides this launched our as recently, running we to base very substantial penetration but it offering the I path. give well these product our tests. product Since attractive We're customer not factored and to very new our of believe see to yet it solution revenues completes
and for and customers about focused haven't said margin we we'll to allocated marketing the are Nonetheless, of we're in is we've this do once various volume, divert high reached onboarding. I much this next I high to product know we that resources several goals, more to in little we've because our year, stages HemeScreen. IV-Cell and Therefore, think IV-Cell. production on us attention product. [IV-Cell], have very sales our who able evaluation achieved financial pipeline out validation be
independence gets matter a identifying priorities we're strategy for the towards product picture Someone It's asked company. the striving Big this of this year. financial in faith of contrary. which if you the to lost quite technology, us
only of has Although become available a these with of company $X $XXX and million, product per market lines, a to billion total a couple HemeScreen has you $XXX total lines. two get are and of million approximately product don't a year IV-Cell
flow independence. This a achieving covering of goal, year sales to want eliminate cash access We first source as and are focused and is solely burn. our which order, all financial on In our golden is R&D to marketing markets breakeven our about teams reach HemeScreen, that needs goose. to capital and cash
in reliance as on XXXX we from that, expansion product development reaches one team focusing and This our to product attention attention into its R&D technology goal, HemeScreen reach portfolio will said new Having suite the of the turn expanding to plan a areas. technologies our product and and the these the platform, on perspective, revenue developing can stream to their other our reducing create new company's risk technologies. diversity
metrics. discuss let's cutting cost our Next,
want cost I company. in clear, a about operated not just initiative be in First, a business in very there's SaaS always to This to manner. an ways little manner. the more in lean cutting is effective run exercise our out because We're this very the identifying better simply is
into impact effect their reducing Initiatives of like our will are changes number. how and in we accomplish Other net using have cash all transitions similar the efficiencies involve positive pathologist Restructuring a being inventory taken at put annually. are already in we initiatives operations a over cash that billing aimed $XX do spend place operational million better workflow and impact. business, management, projecting
Our monthly cash burn the that continues we're looking is and at. drop to key number
be In different this zero the make. be mark, passes founded, company. happiest the we was company the very that announcement will it would get the think a news years since When XX to I
let's like raise stagnation that the will is most of multiple the and concern notion the capital. is than reason I drivers the complex our driver in in frustrated price. to overhang the this, mechanisms analysis the But us share key Finally, sorting more This more talk is situations, other main market. price price. there about seeing any company share to to our potential in the tells on Nobody are have
roadmap additional At cash point, believe to will breakeven, go to will for position, As and to burn. deliver our the capital to we market the that subside. need realizes back results we market the we pressure as downward raise our cash to continue not
to going additional and At of not reach that continue market, shows financial The independence. for news the to end no path going global model day, we us excuses sit I'm the to economy. some give good needs our the execute to with we're Now is we're get to company raise. capital here the on, if along that our
the There X hold. we're reverse , one allow $X for know room, obviously to there's you in is elephant split. negative remind the connotations the doing of factors. all actuating of for a around value of lot merely prepared all As Number the in split, reverse of I bill. reverse exchange which the reverse no bills scenarios, includes anyone's split of XX few a impact is me split $XX for
split the a This shareholder, a in company is its connotation there typically a without holding a not is change shares case you're value. from company to in The number performing. reverse arises while When it true split, reverse no change to is not decides that share when situation. for the company. the value every of all increases the for same perform decreasing the market price And a Precipio negative is the
to our all with go split. burn cash scenario we on what cash breakeven in a of bank. reverse we reducing We pathway the from the a want are That growing and funds. companies have clear many We're different very is to have
back took stock in can addition, at and more In split price the our investors the where reverse the range stock. into consider look many investing
of As stock. brokers minimums I'm any and for many trade are $X you have them or in sure to banks aware, $X
the back demand reverse profit a immediately range, is into share price in oftentimes that to see split. their Moving significant stock companies expands after why price which
order level, I company the to that doing to that. on in right to to Now, perform obviously, we're maintain just think track the has continue and
the course, not to this to shareholders this happens, value changing may that we with if benefits would. of we Of mathematical of we at result like think that if Would us. it compliance I some the that is end the continue organically? agree a loan as transaction, a But - our regain perform, is day, in also
will have company value on market reducing When revenue, discussed reaching now, the we doubt our focus that worth. today, increasing what aspects I've is I is costs, us Right this deliver at really the those, no breakeven.
thank the and again with results. nice quarterly evening. to want I you look attending have a and you, you next for Thank our call today, connecting forward to in I
